 |
|
 |
|
|
Programs and Services
|
 |
|
Continues to support the Talecris AlphaKit testing program to expand diagnosis and awareness of alpha1-antitrypsin (AAT) deficiency
| Of the 80,000-100,000 people estimated to have AAT deficiency, less than 5% have been diagnosed. Do your part to identify people with AAT deficiency by ordering your free AlphaKit |
|
|
|
|
Prolastin DirectSM delivers Prolastin® directly to the patients’ location of choice and provides information and tools to help patients manage their AAT deficiency |
|
|
|
Provides ongoing funding and support of the Alpha-1 community through investments in research initiatives through the Alpha-1 Foundation |
|
|
|
Continues to be a major contributor to the Alpha-1 Association patient activities and regional education days |
Research and Development
|
|
|
Working to perfect new manufacturing technologies that will increase current production capacity, as well as develop new products to help improve the quality of life for people living with AAT deficiency |
|
|
|
Talecris continues to lead the industry in pathogenic prion research |
Important Safety Information
Prolastin®, Alpha1-Proteinase Inhibitor (Human) is indicated for chronic replacement therapy of individuals having congenital deficiency of alpha-1 PI (alpha1-antitrypsin deficiency) with clinically demonstrable panacinar emphysema. Weekly Prolastin® therapy has demonstrated a low occurrence of side effects. In clinical studies with Prolastin®, reactions were observed in 1.16% of infusions, the most common events being fever (0.77%), light-headedness (0.19%), and dizziness (0.19%). As with all plasma-derived therapeutics, the potential to transmit infectious agents cannot be totally eliminated. Individuals with selective IgA deficiencies who have known antibody against IgA (anti-IgA antibody) should not receive Prolastin®, since these patients may experience severe reactions, including anaphylaxis, to IgA which may be present.
You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please click here for Prolastin® full Prescribing Information.
Remember, your doctor or healthcare provider is the single best source of information regarding you and your health. Please consult your doctor or healthcare provider if you have any questions about your health or any of your medications.
|
|
|
|
|